Andrew E Greenstein

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 26, 2023
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study.

Nicoletta Colombo, Toon Van Gorp, Ursula A Matulonis

|Feb 22, 2023
Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody.

Maile Velasquez, Chris O'Sullivan, Robert Brockett

|May 18, 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.

Pamela N Munster, Andrew E Greenstein, Gini F Fleming

|Jun 25, 2021
An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model.

Gheed Al-Hity, FengWei Yang, Eduard Campillo-Funollet

Pageof 1